This contract expires in 337 days (Aug 15, 2027).

Browse related active opportunities

ABT GLOBAL LLC - NEW AWARD EVALUATION OF THE CELL AND GENE THERAPY ACCESS MODEL 75FCMC19D0080/75FCMC24F0135

PIID: 75FCMC24F0164
Signed Date: Aug 15, 2024Effective Date: Aug 16, 2024End Date: Closes in 337 days
Award $
$6.4M
Vendor
ABT GLOBAL LLC
NAICS
541720
Signed Date
Aug 15, 2024

Key Details

Dollars Obligated
$6.4M
Base & All Options
$15.5M
Awarding Sub-Agency
Centers for Medicare and Medicaid Services
Parent IDIQ (PIID)
75FCMC19D0080
Product Service Code
AN42 - HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH
Extent Competed
FULL AND OPEN COMPETITION
Number of Offers
3
Place of Performance
WINDSOR MILL, MD

Description

NEW AWARD EVALUATION OF THE CELL AND GENE THERAPY ACCESS MODEL 75FCMC19D0080/75FCMC24F0135

Context & Analysis

On Aug 15, 2024, Department of Health and Human Services obligated $6,387,451 to ABT GLOBAL LLC for new award evaluation of the cell and gene therapy access model 75fcmc19d0080/75fcmc24f0135. The award is classified under NAICS 541720 — RESEARCH AND DEVELOPMENT IN THE SOCIAL SCIENCES AND HUMANITIES. Competition extent: full and open competition with 3 offers received. Performance is located in WINDSOR MILL, MD. The contract is scheduled through Aug 15, 2027 — approximately 11 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541720 — related awards are listed below.

Contractor Information

Contractor: ABT GLOBAL LLC
UEI: C9S1NLQ67626
Location: ROCKVILLE, MD

Stay Updated

Get notified about new opportunities matching your interests.

Related